Member Exclusive

US$62 million to advance drug candidate for hearing loss

Frequency Therapeutics (MA, USA), specialists in clinical-stage biotechnology products, has completed financing US$62 million for their Series C project.

Go to the profile of RegMedNet
Jul 26, 2019

Please sign in or register for FREE

No comments yet.